NCT07460765 2026-03-10Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)Vanderbilt-Ingram Cancer CenterPhase 1 Not yet recruiting40 enrolled
NCT04391049 2026-01-30Testing the Addition of the Anti-cancer Viral Therapy Telomelysinâ„¢ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for SurgeryNRG OncologyPhase 1 Active not recruiting16 enrolled 15 charts